百克生物(688276) - 2023 Q3 - 季度财报
BCHTBCHT(SH:688276)2023-10-23 16:00

Financial Performance - The company's operating revenue for Q3 2023 reached ¥683,549,070.41, representing a year-on-year increase of 60.91%[4] - The net profit attributable to shareholders for Q3 2023 was ¥219,709,748.78, up 58.92% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was ¥219,378,788.86, reflecting a 70.60% increase year-on-year[4] - Basic earnings per share for Q3 2023 were ¥0.53, an increase of 60.61% compared to the previous year[5] - Total operating revenue for the first three quarters of 2023 reached ¥1,243,193,321.15, a significant increase from ¥865,713,984.64 in the same period of 2022, representing a growth of approximately 43.6%[15] - Net profit for Q3 2023 was ¥363,507,360.41, compared to ¥243,406,534.51 in Q3 2022, reflecting a year-over-year increase of about 49.5%[29] - The total comprehensive income for Q3 2023 was CNY 319,662,845.96, compared to CNY 208,171,383.27 in Q3 2022, marking a growth of 53.6%[19] Assets and Liabilities - Total assets as of the end of Q3 2023 amounted to ¥4,792,559,889.42, an increase of 11.88% from the end of the previous year[5] - The total assets of the company reached ¥4,792,559,889.42, up from ¥4,283,551,750.23 at the end of 2022, indicating a growth of approximately 11.9%[14] - The total liabilities amounted to ¥943,763,771.50, compared to ¥724,015,550.19 at the end of 2022, reflecting an increase of about 30.3%[14] - The total liabilities as of September 30, 2023, were ¥857,152,392.48, compared to ¥705,634,256.49 at the end of 2022, reflecting an increase of approximately 21.5%[26] - The equity attributable to shareholders increased to ¥3,848,796,117.92 from ¥3,559,536,200.04, showing a growth of approximately 8.1%[14] - The company's total equity reached ¥4,140,526,404.00, up from ¥3,818,852,314.92 year-over-year, representing a growth of about 8.4%[27] Cash Flow - The company reported a net cash flow from operating activities of ¥119,764,590.55 for the year-to-date period, attributed to increased sales collections[4][7] - The company reported a net cash flow from operating activities of CNY 119,764,590.55, a significant improvement from a negative cash flow of CNY -94,352,900.10 in Q3 2022[23] - The net cash flow from operating activities for Q3 2023 was -17,094,313.40 RMB, an improvement from -94,868,147.75 RMB in the same period of 2022, indicating a significant reduction in cash outflow[30] - Total cash inflow from operating activities reached 879,893,385.98 RMB, compared to 704,887,449.50 RMB in the previous year, reflecting a year-over-year increase of approximately 24.8%[30] - Cash outflow for the acquisition of fixed assets and other long-term assets was 184,638,103.59 RMB, significantly higher than 99,400,022.64 RMB in Q3 2022, indicating increased investment in capital expenditures[30] - The ending balance of cash and cash equivalents decreased to 453,650,345.19 RMB from 934,265,200.60 RMB year-over-year, reflecting a decline of approximately 51.5%[31] Research and Development - R&D investment for Q3 2023 totaled ¥39,346,952.12, accounting for 5.76% of operating revenue, a decrease of 2.56 percentage points year-on-year[5] - Research and development expenses rose to CNY 136,687,474.68, up 37.7% from CNY 99,284,937.31 in the same period last year[19] - Research and development expenses for the first three quarters of 2023 were ¥126,006,417.52, compared to ¥99,284,937.31 in the same period of 2022, an increase of about 27%[28] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,279[8] - The largest shareholder, Changchun High-tech Industry (Group) Co., Ltd., holds 41.54% of the shares[8] Other Information - The company did not report any significant new strategies or product developments during the quarter[10] - The company incurred a financial expense of CNY -10,547,031.44, an improvement from CNY -15,932,602.36 in the previous year[19] - The total tax expenses for Q3 2023 were CNY 42,395,782.84, compared to CNY 29,997,331.90 in Q3 2022, reflecting a 41.2% increase[19] - The company reported a decrease in other comprehensive income, with a net amount of -¥11,430,343.25 for Q3 2023, compared to -¥3,649,771.43 in Q3 2022[29]